Navigation Links
Hologic Announces First Quarter Fiscal 2008 Operating Results
Date:1/31/2008

exclude the increase in cost of revenues resulting from the

write-up of acquired Cytyc inventory sold during the first quarter of

fiscal 2008.

(4) To exclude the non-cash expense associated with the write-off of

certain intangible assets acquired from Cytyc in the first quarter of

fiscal 2008.

(5) To exclude the non-cash expense associated with the write-off the

acquired in-process research and development related to the

acquisition of Cytyc in the first quarter of fiscal 2008.

(6) To reflect the tax effect at an estimated effective rate of 36% of

adjustments (1), (2), (3) and (4) above.

(7) To reflect the tax effect at an estimated effective rate of 38% of

adjustment (1) and (2) above.

Contact:

Glenn P. Muir Frances Crecco

Executive Vice President & CFO Director, Investor Relations

Hologic, Inc. Hologic, Inc.

(781) 999-7300 (781) 999-7377


'/>"/>
SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Hologic, Inc. to Release First Quarter Fiscal 2008 Operating Results Thursday, January 31st Before Market Opens
2. Hologic to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...leEnergyCorp.announcedtodaythatthecompanyandtheOde...rded$2millionbyWashingtonState,sCommunityEconomicR...iptoconstructthestate,sfirstspecialtybiochemicalbi...willsignificantlyspeedthedevelopmentofourbiorefine...MarbleEnergyCEOKellyOgilvie."WearegratefultotheGov...
(Date:11/24/2009)...patientswithadvanced-stage,orrecurrentendometrialc...ll/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the...nendocrinetherapyandoncology,todayannouncedpositiv...xicpeptideconjugate,AEZS-108(formerlyAN-152),inpat...ersonalizedhealthcareapproach,thestudyselectedpati...
(Date:11/24/2009)...ll/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobalsp...tithassubmittedaMAAtotheEuropeanMedicinesAgencyfor...erapyindevelopment,forthetreatmentofType1Gaucherdi...ucerasealfathathasbeensubmitted,withprevious,submi...lobalsupplyshortageofthecurrentlyapprovedandmarket...
(Date:11/24/2009)...-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )toda...hairman,willpresentatthe21stAnnualPiperJaffrayHeal...009at10:00a.m.ET. ,, Toaccesstheliveandsubseque...torRelationssectionofGenomicHealth,swebsiteat http...ebsiteatleast15minutespriortothebeginningofthepres...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2
...need is a good idea to make some good money. You c...me registration for a year for much less than $1 a...per month. For an additional $3 a month, get an en...fer secure online credit-card transactions. Cha-ch...n in for free. In principle you will have almost t...
...s. The Madison police department has moved to sp...ddition of an eToken USB key system provided by A...vide a robust and dependable situation thats easil...focus on protecting the city of Madison with unpar...on, said Neil Sullivan, the companys enterprise se...
...fices are located in the MG&E Innovation Center at...al research group ConjuGon announced on Tuesday ...of $1.1 million dollars from angel investors, incl...e new funds will be directed to the firms operatin...otheraputic treatments. , ,ConjuGon develops remed...
Other Biology Technology:The Wal-Mart-ization of e-commerce 2The Wal-Mart-ization of e-commerce 3Madison police adopt digital lock and key 2ConjuGon lands $1 million angel investment 2
(Date:11/23/2009)...for 360 million years and survived when the dinosa...g to make many of them extinct, according to an ar... . , The fungus, Batrachochytrium dendrobatidi...amphibian extinctions in Central America and north...350 amphibian species by penetrating their skin, b...
(Date:11/23/2009)...x-week-old turkey poults could save millions of ma...ccording to Dr. Gerald Steiner from the Dresden Un...eir use of infrared spectroscopy to determine the ...accurate method with the potential to be used by t... eggs for breeding. The pilot study has just been ...
(Date:11/23/2009)... Interuniversity Professorship in Law and the Huma...of the Basque Country. The Professorship is largel...ch as researchers in the fields of molecular biolo...he Interuniversity Professorship in Law and the Hu...Basque Country was created in 1993. The worldwide ...
Breaking Biology News(10 mins):Rescuing male turkey chicks 2Research and legislation should go hand in hand, as much as possible 2Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 1Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 2Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 3Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 4Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 5Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 6Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 7Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 8Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 9Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 10Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 11Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 12Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 13Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 14Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 15Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 16Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 17Intercept Pharmaceuticals Announces Positive Phase II Results for INT 747 as a Treatment for Primary Biliary Cirrhosis 5726 1Intercept Pharmaceuticals Announces Positive Phase II Results for INT 747 as a Treatment for Primary Biliary Cirrhosis 5726 2Intercept Pharmaceuticals Announces Positive Phase II Results for INT 747 as a Treatment for Primary Biliary Cirrhosis 5726 3Success Targeting Competencies Missed in Traditional Testing Leads to Selection of Amistaff for Poster Presentations on Prophecy 26apos 3Bs Video Base 60135 1Success Targeting Competencies Missed in Traditional Testing Leads to Selection of Amistaff for Poster Presentations on Prophecy 26apos 3Bs Video Base 60135 2Success Targeting Competencies Missed in Traditional Testing Leads to Selection of Amistaff for Poster Presentations on Prophecy 26apos 3Bs Video Base 60135 3Success Targeting Competencies Missed in Traditional Testing Leads to Selection of Amistaff for Poster Presentations on Prophecy 26apos 3Bs Video Base 60135 4
...in, reward and addictive behaviors. Opioids exert ... receptors, mu, delta and kappa whose genes have b...Opioid receptors in the brain are activated by a f...orphins and endorphin, which are released by neuro...usly by alkaloid opiates, the prototype of which i...
...ry J. Hannon, Ph.D., Cold Spring Harbor Laboratory...ute (HHMI) investigator, along with two other youn...rial Sloan-Kettering Cancer Centers (MSKCC) 2007 P... named after Paul A. Marks, Ph.D., President Emeri... to the basic understanding and treatment of cance...
...m aimed at linking together the world,s databases ... the Nobel Prize for Medicine awarded to Mario R. ... launched this week. , The Cambridge University... will ultimately support new medical advances and ...esearch. , Because they are so genetically simila...
Other Biology News:How does the opioid system control pain, reward and addictive behavior? 2How does the opioid system control pain, reward and addictive behavior? 3How does the opioid system control pain, reward and addictive behavior? 4Gregory Hannon wins 2007 Paul Marks Prize for contributions to understanding and treating cancer 2A computer for your mouse! 2
...FREEZE/THAW CYCLES. An assay kit designed to detec...estern blotting. PARP is an enzyme implicated in D... PARP is cleaved by caspase-3. Cleavage of PARP fr...poptosis. Each kit is provided with a highly speci...
...cal to the DH-2000, but comes with a shutter (cont...e DH-2000 Deuterium Tungsten Halogen Light Source... tungsten halogen light sources in a single optica...s a powerful, stable output from 215-200 nm. In ad...
Agilent MSD Security ChemStation for GC and GC/MS from Agilent Technologies
...rrays designed for genome-wide microRNA expression...Paraflo microfluidic on-chip synthesis platform. T...rehensive microRNA Expression Profiling Service. ...ray contains all known soil nematode microRNAs (11...
Biology Products: